Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors
Authors:
- 31 March 2008
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 47 (7) , 573-590
Abstract
The pathogenesis of multiple myeloma (MM) is thought to involve at least two pathways, which generate hyperdiploid (HRD) or nonhyperdiploid (NHRD) tumors, respectively. Apart from chromosome content, the two pathways are distinguished by five primary immunoglobulin heavy chain (IGH) rearrangements (4p16, FGFR3, and MMSET; 6p21, CCND3; 11q13, CCND1; 16q23, MAF; 20q12, MAFB) that are present mainly in NHRD tumors. To determine the prevalence and structures of IGH, immunoglobulin (IG) light chain, and MYC genomic rearrangements in MM, we have done comprehensive metaphase fluorescent in situ hybridization analyses on 48 advanced MM tumors and 47 MM cell lines. As expected, the prevalence of the five primary IGH rearrangements was nearly 70% in NHRD tumors, but only 12% in HRD tumors. However, IGH rearrangements not involving one of the five primary partners, and IG light chain rearrangements, have a similar prevalence in HRD and NHRD tumors. In addition, MYC rearrangements, which are thought to be late progression events that sometimes do not involve an IG heavy or light chain locus, also have a similar prevalence in HRD and NHRD tumors. In contrast to the primary IGH rearrangements, which usually are simple balanced translocations, these other IG rearrangements usually have complex structures, as previously described for MYC rearrangements in MM. We conclude that IG light chain and MYC rearrangements, as well as secondary IGH rearrangements, make similar contributions to the progression of both HRD and NHRD MM tumors. Published 2008 Wiley‐Liss, Inc.Keywords
This publication has 30 references indexed in Scilit:
- Characterization of MYC Translocations in Multiple Myeloma Cell LinesJNCI Monographs, 2008
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression ProfilingCancer Research, 2007
- Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myelomaGenes, Chromosomes and Cancer, 2006
- Cyclin D dysregulation: an early and unifying pathogenic event in multiple myelomaBlood, 2005
- Genetics and Cytogenetics of Multiple MyelomaCancer Research, 2004
- Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid casesGenes, Chromosomes and Cancer, 2003
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002